Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease

References

• Agbaedeng TA, Noubiap JJ, Mofo Mato EP, Chew DP, Figtree GA, Said MA, van der Harst P. 2021. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data. Atherosclerosis. 333:48–55. doi:10.1016/j.atherosclerosis.2021.08.020
   PubMedGoogle Scholar
• Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, Ryan CF, Fleetham J, Choi P, Ayas NT. 2007. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: A meta-analysis of randomized controlled trials. Lung. 185:67–72. doi:10.1007/s00408-006-0117-x
   PubMed Web of Science ®Google Scholar
• Allam AH, Mandour Ali MA, Wann LS, Thompson RC, Sutherland ML, Sutherland JD, Frohlich B, Michalik DE, Zink A, Lombardi GP, et al. 2014. Atherosclerosis in ancient and modern Egyptians: The Horus study. Glob Heart. 9:197–202. doi:10.1016/j.gheart.2014.03.2454
   PubMedGoogle Scholar
• Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart AC, Aber VR, Maseri A, Kluft C. 1988. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol. 62:635–637. doi:10.1016/0002-9149(88)90669-8
   PubMed Web of Science ®Google Scholar
• Andreotti F, Kluft C. 1991. Circadian variation of fibrinolytic activity in blood. Chronobiol Int. 8:336–351. doi:10.3109/07420529109059170
   PubMed Web of Science ®Google Scholar
• Anea CB, Zhang M, Stepp DW, Simkins GB, Reed G, Fulton DJ, Rudic RD. 2009. Vascular disease in mice with a dysfunctional circadian clock. Circulation. 119:1510–1517. PMID: 19273720; PMCID: PMC2761686. doi:10.1161/CIRCULATIONAHA.108.827477.
   PubMed Web of Science ®Google Scholar
• Angleton P, Chandler WL, Schmer G. 1989. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 79:101–106. doi:10.1161/01.cir.79.1.101
   PubMed Web of Science ®Google Scholar
• Aschoff J. 1983. Circadian control of body temperature. J Therm Biol. 8:143–147. doi:10.1016/0306-4565(83)90094-3
   Web of Science ®Google Scholar
• Asher G, Schibler U. 2006. A CLOCK-less clock. Trends Cell Biol. 16:547–549. doi:10.1016/j.tcb.2006.09.005
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. 2010. Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 27:345–362. doi:10.3109/07420521003624662
   PubMed Web of Science ®Google Scholar
• Bagai K, Muldowney JA 3rd, Song Y, Wang L, Bagai J, Artibee KJ, Vaughan DE, Malow BA. 2014. Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea. Sleep. 37:359–367. doi:10.5665/sleep.3414
   PubMedGoogle Scholar
• Bain AR, Weil BR, Diehl KJ, Greiner JJ, Stauffer BL, DeSouza CA. 2017. Insufficient sleep is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation. Atherosclerosis. 265:41–46. doi:10.1016/j.atherosclerosis.2017.08.001
   PubMed Web of Science ®Google Scholar
• Baraldo M. 2008. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 4:175–192. doi:10.1517/17425255.4.2.175
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Fitzgerald GA, Dollery CT. 1982. Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond). 62:349–354. doi:10.1042/cs0620349
   PubMed Web of Science ®Google Scholar
• Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. 2003. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 107:68–73. doi:10.1161/01.cir.0000042706.47107.7a
   PubMed Web of Science ®Google Scholar
• Bélanger PM, Bruguerolle B, Labrecque G. 1997. Rhythms in pharmacokinetics: Absorption, distribution, metabolism, and excretion. In Redfern PH, Lemmer B, editors. Physiology and pharmacology of biological rhythms. Handbook of experimental pharmacology. Berlin-New York: Springer-Verlag. series volume. Vol. 125, p.177–204.
   Google Scholar
• Bhatwadekar AD, Beli E, Diao Y, Chen J, Luo Q, Alex A, Caballero S, Dominguez JM 2nd, Salazar TE, Busik JV, et al. 2017. Conditional deletion of Bmal1 accentuates microvascular and macrovascular injury. Am J Pathol. 187:1426–1435. doi:10.1016/j.ajpath.2017.02.014
   PubMed Web of Science ®Google Scholar
• Blasco-Colmenares E, Moreno-Franco B, Latre ML, Mur-Vispe E, Pocovi M, Jarauta E, Civeira F, Laclaustra M, Casasnovas JA, Guallar E. 2018. Sleep duration and subclinical atherosclerosis: The Aragon workers’ health study. Atherosclerosis. 274:35–40. doi:10.1016/j.atherosclerosis.2018.05.003
   PubMed Web of Science ®Google Scholar
• Bonten TN, Saris A, van Oostrom MJ, Snoep JD, Rosendaal FR, Zwaginga J, Eikenboom J, van der Meer PF, van der Bom JG. 2014. Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. Thromb Haemost. 112:1209–1218. doi:10.1160/TH14-05-0453
   PubMed Web of Science ®Google Scholar
• Bonten TN, Snoep JD, Assendelft WJ, Zwaginga JJ, Eikenboom J, Huisman MV, Rosendaal FR, van der Bom JG. 2015. Time-dependent effects of aspirin on blood pressure and morning platelet reactivity: a randomized cross-over trial. Hypertension. 65:743–750. doi:10.1161/HYPERTENSIONAHA.114.04980
   PubMed Web of Science ®Google Scholar
• Borbély AA. 1982. A two process model of sleep regulation. Hum Neurobiol. 1:195–204.
   PubMedGoogle Scholar
• Borbély AA, Achermann P. 1999. Sleep homeostasis and models of sleep regulation. J Biol Rhythm. 14:559–570. doi:10.1177/AQ5074873099129000894
   Web of Science ®Google Scholar
• Borbély AA, Daan S, Wirz-Justice A, Deboer T. 2016. The two-process model of sleep regulation: a reappraisal. J Sleep Res. 25:131–143. doi:10.1111/jsr.12371
   PubMed Web of Science ®Google Scholar
• Bratton DJ, Gaisl T, Wons AM, Kohler M. 2015. CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. JAMA. 314:2280–2293. doi:10.1001/jama.2015.16303
   PubMed Web of Science ®Google Scholar
• Brezinski DA, Tofler GH, Muller JE, Pohjola-Sintonen S, Willich SN, Schafer AI, Czeisler CA, Williams GH. 1988. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation. 78:35–40. doi:10.1161/01.cir.78.1.35
   PubMed Web of Science ®Google Scholar
• Bridges AB, Fisher TC, Scott N, McLaren M, Belch JJ. 1992a. Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res Commun. 16:89–97. doi:10.3109/10715769209049162
   PubMed Web of Science ®Google Scholar
• Bridges AB, Scott NA, McNeill GP, Pringle TH, Belch JJ. 1992b. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J. 13:1632–1636. doi:10.1093/oxfordjournals.eurheartj.a060116
   PubMed Web of Science ®Google Scholar
• Brooks PM, Cossum PA, Boyd GW. 1980. Rebound rise in renin concentrations after cessation of salicylates. N Engl J Med. 303:562–564. doi:10.1056/NEJM198009043031006
   PubMed Web of Science ®Google Scholar
• Brown A, Smolensky M, D’Alonzo G, Frankhoff H, Gianotti L, Nilsestuen J. 1988. Circadian chronesthesy of the ß-agonist bronchodilator isoproterenol. Ann Rev Chronopharm. 5:163–166.
   Google Scholar
• Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. 1998. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension. 32:965–971. doi:10.1161/01.hyp.32.6.965
   PubMed Web of Science ®Google Scholar
• Bruguerolle B. 1998. Chronopharmacokinetics. Current Status Clin Pharmacokinet. 35:83–94. doi:10.2165/00003088-199835020-00001
   PubMed Web of Science ®Google Scholar
• Budkowska M, Lebiecka A, Marcinowska Z, Woźniak J, Jastrzębska M, Dołęgowska B. 2019. The circadian rhythm of selected parameters of the hemostasis system in healthy people. Thromb Res. 182:79–88. doi:10.1016/j.thromres.2019.08.015
   PubMed Web of Science ®Google Scholar
• Burris TP. 2008. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. Mol Endocrinol. 22:1509–1520. doi:10.1210/me.2007-0519
   PubMed Web of Science ®Google Scholar
• Butler MJ, Spruill TM, Johnson DA, Redline S, Sims M, Jenkins BC, Booth JN 3rd, Thomas SJ, Abdalla M, O’Brien EC, et al. 2020. Suboptimal sleep and incident cardiovascular disease among African Americans in the Jackson Heart Study (JHS). Sleep Med. 76:89–97. doi:10.1016/j.sleep.2020.09.005
   PubMedGoogle Scholar
• Buurma M, van Diemen JJK, Thijs A, Numans ME, Bonten TN. 2019. Circadian rhythm of cardiovascular disease: The potential of chronotherapy with aspirin. Front Cardiovasc Med. 6:84. doi:10.3389/fcvm.2019.00084
   PubMed Web of Science ®Google Scholar
• Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ. 2008. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res. 102:1359–1367. doi:10.1161/CIRCRESAHA.108.174235
   PubMedGoogle Scholar
• Castriotta RJ. 2017. J Sense and sensitivity: Obstructive sleep apnea, morning blood pressure, and occult hypertension. J Clin Sleep Med. 13:861–862. doi:10.5664/jcsm.6652
   PubMedGoogle Scholar
• Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G. 1999. Aldosterone release during the sleep-wake cycle in humans. Am J Physiol. 276:E43–49. doi:10.1152/ajpendo.1999.276.1.E43
   PubMedGoogle Scholar
• Chen Z, Yoo SH, Park YS, Kim KH, Wei S, Buhr E, Ye ZY, Pan HL, Takahashi JS. 2012. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc Natl Acad Sci U S A. 109:101–106. doi:10.1073/pnas.1118034108
   PubMed Web of Science ®Google Scholar
• Cherubini JM, Cheng JL, Williams JS, MacDonald MJ. 2021. Sleep deprivation and endothelial function: Reconciling seminal evidence with recent perspectives. Am J Physiol Heart Circ Physiol. 320:H29–H35. doi:10.1152/ajpheart.00607.2020
   PubMed Web of Science ®Google Scholar
• Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, et al. 2012. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature. 485:123–127. doi:10.1038/nature11048
   PubMed Web of Science ®Google Scholar
• Chong NW, Codd V, Chan D, Samani NJ. 2006. Circadian clock genes cause activation of the human PAI-1 gene promoter with 4G/5G allelic preference. FEBS Lett. 580:4469–4472. doi:10.1016/j.febslet.2006.07.014
   PubMedGoogle Scholar
• Chung S, Lee EJ, Yun S, Choe HK, Park SB, Son HJ, Kim KS, Dluzen DE, Lee I, Hwang O, et al. 2014. Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell. 157:858–868. doi:10.1016/j.cell.2014.03.039
   PubMed Web of Science ®Google Scholar
• Covassin N, Singh P. 2016. Sleep duration and cardiovascular disease risk: Epidemiologic and experimental evidence. Sleep Med Clin. 11:81–89. doi:10.1016/j.jsmc.2015.10.007
   PubMed Web of Science ®Google Scholar
• Crippa G, Zabzuni D, Cassi A, Bravi E. 2016. Effect of bedtime dosing of barnidipine hydrochloride in non-dipper hypertensive patients with obstructive sleep apnoea not treated with continuous positive airway pressure. Eur Rev Med Pharmacol Sci. 20:339–344.
   PubMedGoogle Scholar
• Cugini P, Scavo D, Cornelissen G, Lee JY, Meucci T, Halberg F. 1981a. Circadian rhythms of plasma renin, aldosterone and cortisol on habitual and low dietary sodium intake. Horm Res. 15:7–27. doi:10.1159/000179430
   PubMedGoogle Scholar
• Cugini P, Scavo D, Halberg F, Sothern RB, Cornelissen G, Meucci T, Salandi E, Massimiani F. 1981b. Ageing and circadian rhythm of plasma renin and aldosterone. Maturitas. 3:173–182. doi:10.1016/0378-5122(81)90009-8
   PubMed Web of Science ®Google Scholar
• Cugini P, Letizia C, Scavo D. 1988. The circadian rhythmicity of serum angiotensin converting enzyme: Its phase relation with the circadian cycle of plasma renin and aldosterone. Chronobiologia. 15:229–232.
   PubMedGoogle Scholar
• Curtis AM, Cheng Y, Kapoor S, Reilly D, Price TS, Fitzgerald GA. 2007 Feb 27. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A. 104:3450–3455. doi:10.1073/pnas.0611680104
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Tadic M, Sala C, Gherbesi E, Grassi G, Mancia G. 2019. Blood pressure non-dipping and obstructive sleep apnea syndrome: A meta-nalysis. J Clin Med. 8:1367. doi:10.3390/jcm8091367
   PubMedGoogle Scholar
• De Juan A, Ince LM, Pick R, Chen CS, Molica F, Zuchtriegel G, Wang C, Zhang D, Druzd D, Hessenauer MET, et al. 2019. Artery-associated sympathetic innervation drives rhythmic vascular inflammation of arteries and veins. Circulation. 140:1100–1114. doi:10.1161/CIRCULATIONAHA.119.040232
   PubMedGoogle Scholar
• De Mello WC, Frohlich ED. 2011. On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides. 32:1774–1779. doi:10.1016/j.peptides.2011.06.018
   PubMed Web of Science ®Google Scholar
• Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, De Bonadona JF, Reinberg A, Queneau PM. 1985a. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J (Clin Res Ed). 290:341–344. doi:10.1136/bmj.290.6465.341
   PubMed Web of Science ®Google Scholar
• Decousus H, Croze M, Levi F, Jaubert J, Perpoint B, Reinberg A, Queneau P. 1985b. Variation nycthémérale de l’effet anticoagulant de l’héparine administrée à débit constant par voie intraveineuse [Nycthemeral change in the anticoagulant effect of heparin given at a constant rate by the intravenous route]. C R Acad Sci III. 300:385–388. French.
   PubMed Web of Science ®Google Scholar
• Dell’Italia LJ. 2011. Translational success stories: angiotensin receptor 1 antagonists in heart failure. Circ Res. 109:437–452. doi:10.1161/CIRCRESAHA.110.238550
   PubMed Web of Science ®Google Scholar
• Deol R, Lee KA, Kanaya AM, Kandula NR. 2020. Obstructive sleep apnea risk and subclinical atherosclerosis in South Asians living in the United States. Sleep Health. 6:124–130. doi:10.1016/j.sleh.2019.09.007
   PubMedGoogle Scholar
• DeVries GJT, Booy-Noord ONG. 1962. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy Appl Immunol. 20:93–101. doi:10.1159/000229248
   PubMedGoogle Scholar
• Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517–549. doi:10.1146/annurev-physiol-021909-135821
   PubMed Web of Science ®Google Scholar
• Dickson ME, Sigmund CD. 2006. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension. 48:14–20. doi:10.1161/01.HYP.0000227932.13687.60
   PubMedGoogle Scholar
• Dierickx P, Emmett MJ, Jiang C, Uehara K, Liu M, Adlanmerini M, Lazar MA. 2019 Jun 18. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. Proc Natl Acad Sci U S A. 116:12147–12152. doi:10.1073/pnas.1904226116
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. 2005. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 46:156–161. doi:10.1161/01.HYP.0000170138.56903.7a
   PubMed Web of Science ®Google Scholar
• Domínguez F, Fuster V, Fernández-Alvira JM, Fernández-Friera L, López-Melgar B, Blanco-Rojo R, Fernández-Ortiz A, García-Pavía P, Sanz J, Mendiguren JM, et al. 2019. Association of sleep duration and quality with subclinical atherosclerosis. J Am Coll Cardiol. 73:134–144. doi:10.1016/j.jacc.2018.10.060
   PubMed Web of Science ®Google Scholar
• Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, et al.; Spanish Sleep and Breathing Group. 2010. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: Randomised controlled trial. BMJ. 341:c5991. doi:10.1136/bmj.c5991
   PubMedGoogle Scholar
• Durante A, Peretto G, Laricchia A, Ancona F, Spartera M, Mangieri A, Cianflone D. 2012. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des. 18:981–1004. doi:10.2174/138161212799436467
   PubMed Web of Science ®Google Scholar
• Dutheil F, Baker JS, Mermillod M, De Cesare M, Vidal A, Moustafa F, Pereira B, Navel V. 2020. Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis. Atherosclerosis. 313:156–169. doi:10.1016/j.atherosclerosis.2020.08.015
   PubMed Web of Science ®Google Scholar
• Dzau VJ. 2001. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension. 37:1047–1052. doi:10.1161/01.HYP.37.4.1047
   PubMed Web of Science ®Google Scholar
• Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, Dilag-Penilla SA, Dyar KA, Baldi P, Sassone-Corsi P. 2013. Reprogramming of the circadian clock by nutritional challenge. Cell. 155:1464–1478. doi:10.1016/j.cell.2013.11.034
   PubMed Web of Science ®Google Scholar
• Eguchi K, Shimizu M, Hoshide S, Shimada K, Kario K. 2012. A bedtime dose of ARB was better than a morning dose in improving baroreflex sensitivity and urinary albumin excretion – The J-TOP study. Clin Exp Hypertens. 34:488–492. doi:10.3109/10641963.2012.666604
   PubMed Web of Science ®Google Scholar
• Ekholm M, Kahan T. 2021. The impact of the renin-angiotensin-aldosterone system on inflammation, coagulation, and atherothrombotic complications, and to aggravated COVID-19. Front Pharmacol. 12:640185. doi:10.3389/fphar.2021.640185
   PubMedGoogle Scholar
• Escudero P, Martinez de Marañón A, Collado A, Gonzalez-Navarro H, Hermenegildo C, Peiró C, Piqueras L, Sanz MJ. 2015. Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions. Antioxid Redox Signal. 22:901–920. doi:10.1089/ars.2014.5969
   PubMed Web of Science ®Google Scholar
• Ferrario CM. 2016. Cardiac remodelling and RAS inhibition. Ther Adv Cardiovasc Dis. 10:162–171. doi:10.1177/1753944716642677
   PubMedGoogle Scholar
• Ferreira AJ, Santos RA, Raizada MK. 2012. Angiotensin-(1-7)/angiotensin-converting enzyme 2/mas receptor axis and related mechanisms. Int J Hypertens. 2012:690785. doi:10.1155/2012/690785
   PubMedGoogle Scholar
• Figueiro MG, Goo YH, Hogan R, Plitnick B, Lee JK, Jahangir K, Moulik M, Yechoor VK, Paul A. 2021. Light-dark patterns mirroring shift work accelerate atherosclerosis and promote vulnerable lesion phenotypes. J Am Heart Assoc. 10:e018151. doi:10.1161/JAHA.120.018151
   PubMedGoogle Scholar
• Fliser D, Buchholz K, Haller H; EUropean Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) Investigators. 2004. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 110:1103–1107. doi:10.1161/01.CIR.0000140265.21608.8E
   PubMed Web of Science ®Google Scholar
• Fraga-Silva RA, Savergnini SQ, Montecucco F, Nencioni A, Caffa I, Soncini D, Costa-Fraga FP, De Sousa FB, Sinisterra RD, Capettini LA, et al. 2014. Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. Thromb Haemost. 111:736–747. doi:10.1160/TH13-06-0448
   PubMed Web of Science ®Google Scholar
• Fujimura A, Ohashi K, Ebihara A. 1992. Daily variations in platelet aggregation and adhesion in healthy subjects. Life Sci. 50:1043–1047. doi:10.1016/0024-3205(92)90099-b
   PubMed Web of Science ®Google Scholar
• Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. 1999. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost. 82:1121–1126. PMID: 10494775. doi:10.1055/s-0037-1614340.
   PubMed Web of Science ®Google Scholar
• Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, Takahashi JS, Weitz CJ. 1998. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280:1564–1569. doi:10.1126/science.280.5369
   PubMed Web of Science ®Google Scholar
• Geng YJ, Libby P. 1 2002. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 22:1370–1380. doi:10.1161/01.atv.0000031341.84618.a4.
   PubMed Web of Science ®Google Scholar
• Geng YJ, Madonna R, Hermida RC, Smolensky MH. 2021. Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions. Cur Res Pharmacol Drug Dis. 2:1–12 (100025). doi:10.1016/j.crphar.2021.100025
   Google Scholar
• Giachelli CM, Steitz S. 2000. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol. 19:615–622. doi:10.1016/s0945-053x(00)00108-6
   PubMed Web of Science ®Google Scholar
• Grant D, Yin L, Collins JL, Parks DJ, Orband-Miller LA, Wisely GB, Joshi S, Lazar MA, Willson TM, Zuercher WJ. 2010. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem Biol. 5:925–932. doi:10.1021/cb100141y
   PubMed Web of Science ®Google Scholar
• Gray SP, Jandeleit-Dahm KA. 2015. The role of NADPH oxidase in vascular disease–hypertension, atherosclerosis & stroke. Curr Pharm Des. 21:5933–5944. doi:10.2174/1381612821666151029112302
   PubMed Web of Science ®Google Scholar
• Grover SP, Mackman N. 2018. Tissue factor: An essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 38:709–725. doi:10.1161/ATVBAHA.117.309846
   PubMed Web of Science ®Google Scholar
• Gunnarsson SI, Peppard PE, Korcarz CE, Barnet JH, Aeschlimann SE, Hagen EW, Young T, Hla KM, Stein JH. 2014. Obstructive sleep apnea is associated with future subclinical carotid artery disease: Thirteen-year follow-up from the Wisconsin sleep cohort. Arterioscler Thromb Vasc Biol. 34:2338–2342. doi:10.1161/ATVBAHA.114.303965
   PubMed Web of Science ®Google Scholar
• Gupta K, Nagalli S, Kalra R, Gupta R, Mahmood S, Jain V, Zhou W, Prabhu SD, Bajaj NS. 2021. Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey. Am J Prev Cardiol. 8:100246. doi:10.1016/j.ajpc.2021.100246
   PubMedGoogle Scholar
• Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, Hoch N, Dikalov S, Rudzinski P, Kapelak B, et al. 2008. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol. 52:1803–1809. doi:10.1016/j.jacc.2008.07.063
   PubMed Web of Science ®Google Scholar
• Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chappell MC. 2010. Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension. 55:166–171. doi:10.1161/HYPERTENSIONAHA.109.141622
   PubMedGoogle Scholar
• Haghayegh S, Smolensky MH, Khoshnevis S, Hermida RC, Castriotta RJ, Diller KR. In press 2021. The Circadian rhythm of thermoregulation modulates both the sleep/wake cycle and 24-hour pattern of arterial blood pressure. Comp Physiol.11(4): 2645–2658. doi:10.1002/cphy.c210008.
   PubMedGoogle Scholar
• Hajar R. 2017. Coronary Heart disease: From mummies to 21st century. Heart Views. 18:68–74. doi:10.4103/HEARTVIEWS.HEARTVIEWS_57_17
   PubMedGoogle Scholar
• Haus E, Cusulos M, Sackett-Lundeen L, Swoyer J. 1990. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiol Int. 7:203–216. doi:10.3109/07420529009056976
   PubMed Web of Science ®Google Scholar
• Haus E. 2007. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev. 59:966–984. doi:10.1016/j.addr.2006.11.002
   PubMed Web of Science ®Google Scholar
• He B, Nohara K, Park N, Park YS, Guillory B, Zhao Z, Garcia JM, Koike N, Lee CC, Takahashi JS, et al. 2016. The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab. 23:610–621. doi:10.1016/j.cmet.2016.03.007
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Ayala DE, Iglesias M, Halberg F. 1994. Time-dependent effects of ASA administration on blood pressure in healthy subjects. Chronobiologia. 21:201–213.
   PubMedGoogle Scholar
• Hermida RC, Fernández JR, Ayala DE, Mojón A, Iglesias M. 1997. Influence of aspirin usage on blood pressure: Dose and administration-time dependencies. Chronobiol Int. 14:619–637. doi:10.3109/07420529709001452
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. 2003. Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension. 41:1259–1267. doi:10.1161/01.HYP.0000072335.73748.0D
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, López JE. 2005a. Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 46:960–968. doi:10.1161/01.HYP.0000174616.36290.fa
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE. 2005b. Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol. 46:975–983. doi:10.1016/j.jacc.2004.08.071
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Rodríguez M, Fernández JR. 2005c. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 46:1060–1068. doi:10.1161/01.HYP.0000172623.36098.4e
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida RC. 2007. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol Int. 24:749–775. doi:10.1080/07420520701535837
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:10.3109/07420528.2010.510230
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173. doi:10.1016/j.jacc.2011.04.043
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013a. Ambulatory blood pressure monitoring: importance of sampling rate and duration–48 versus 24 hours–on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67. doi:10.3109/07420528.2012.701457
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. 2013b. Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 30:68–86. doi:10.3109/07420528.2012.702581
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2013c. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure Level—The “Normotensive Non-dipper” paradox. Chronobiol Int. 30:87–98. doi:10.3109/07420528.2012.701127
   PubMed Web of Science ®Google Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Chronobiol Int. 33:906–936. doi:10.1080/07420528.2016.1181078
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH. 2018a. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. Eur J Clin Invest. 48:e12909. doi:10.1111/eci.12909
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al.; Hygia Project Investigators. 2018b. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:10.1093/eurheartj/ehy475
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al.; Hygia Project Investigators. 2020a. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 41:4565–4576. doi:10.1093/eurheartj/ehz754
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M. 2020b. Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies. Eur Heart J. 41:1602–1603. doi:10.1093/eurheartj/ehaa214
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2020c. Ingestion-time - relative to circadian rhythms - differences in the pharmacokinetics and pharmacodynamics of hypertension medications. Expert Opin Drug Metab Toxicol. 16:1159–1173. doi:10.1080/17425255.2020.1825681
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Otero A, Crespo JJ, Domínguez-Sardiña M, Ríos MT, Smolensky MH. 2020d. Ambulatory blood pressure monitoring-based definition of true arterial hypertension. Minerva Med. 111:573–588. doi:10.23736/S0026-4806.20.06834-2
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Hermida-Ayala RG, Smolensky MH, Fernández JR. 2021a. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials. Sleep Med Rev. 59:101454. doi:10.1016/j.smrv.2021.101454
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2021b. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Adv Drug Deliv Rev. 170:200–213. doi:10.1016/j.addr.2021.01.013
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Mojón A, Smolensky MH, Fernández JR. 2021c. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiol Int. 38:1460–1476. doi:10.1080/07420528.2021.1931280
   PubMed Web of Science ®Google Scholar
• Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. 2016. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 118:535–546. doi:10.1161/CIRCRESAHA.115.307611
   PubMed Web of Science ®Google Scholar
• Hijmans JG, Levy M, Garcia V, Lincenberg GM, Diehl KJ, Greiner JJ, Stauffer BL, DeSouza CA. 2019. Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature. Exp Physiol. 104:975–982. doi:10.1113/EP087469
   PubMed Web of Science ®Google Scholar
• Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. 2002. Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene. Thromb Haemost. 88:794–798. PMID: 12428096. doi:10.1055/s-0037-1613304.
   PubMedGoogle Scholar
• Hogenesch JB, Gu YZ, Jain S, Bradfield CA. 1998. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci U S A. 95:5474–5479. doi:10.1073/pnas.95.10.5474
   PubMed Web of Science ®Google Scholar
• Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K. 2002. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 419:841–844. doi:10.1038/nature01123
   PubMed Web of Science ®Google Scholar
• Hu X, Fan J, Chen S, Yin Y, Zrenner B. 2015. The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich). 17:215–222. doi:10.1111/jch.12472
   PubMed Web of Science ®Google Scholar
• Hui DS, To KW, Ko FW, Fok JP, Chan MC, Ngai JC, Tung AH, Ho CW, Tong MW, Szeto CC, et al. 2006. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax. 61:1083–1090. doi:10.1136/thx.2006.064063
   PubMedGoogle Scholar
• Hurwitz S, Cohen RJ, Williams GH. 2004. Diurnal variation of aldosterone and plasma renin activity: Timing relation to melatonin and cortisol and consistency after prolonged bed rest. J Appl Physiol. 96:1406–1414. doi:10.1152/japplphysiol.00611.2003
   PubMed Web of Science ®Google Scholar
• Husain K. 2015. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World Journal of Biological Chemistry. 6:209–217. doi:10.4331/wjbc.v6.i3.209
   PubMedGoogle Scholar
• Ingelsson E, Björklund-Bodegård K, Lind L, Arnlöv J, Sundström J. 2006. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 295:2859–2866. doi:10.1001/jama.295.24.2859
   PubMed Web of Science ®Google Scholar
• Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. 1992. Circadian variation in platelet function in healthy volunteers. Am J Cardiol. 69:951–954. doi:10.1016/0002-9149(92)90799-5
   PubMed Web of Science ®Google Scholar
• Jankowiak S, Backé E, Liebers F, Schulz A, Hegewald J, Garthus-Niegel S, Nübling M, Blankenberg S, Pfeiffer N, Lackner KJ, et al. 2016. Current and cumulative night shift work and subclinical atherosclerosis: results of the Gutenberg Health Study. Int Arch Occup Environ Health. 89:1169–1182. doi:10.1007/s00420-016-1150-6
   PubMedGoogle Scholar
• Jarjour NN. 1999. Circadian variation in allergen and nonspecific bronchial responsiveness in asthma. Chronobiol Int. 16:631–639. doi:10.3109/07420529908998732
   PubMed Web of Science ®Google Scholar
• Kang W, Park WJ, Jang KH, Kim SH, Gwon DH, Lim HM, Ahn JS, Moon JD. 2016. Coronary artery atherosclerosis associated with shift work in chemical plant workers by using coronary CT angiography. Occup Environ Med. 73:501–505. doi:10.1136/oemed-2015-103118
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. 1997. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation. 96:19–21. doi:10.1161/01.cir.96.1.19
   PubMed Web of Science ®Google Scholar
• Kario K. 2009. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res. 32:428–432. doi:10.1038/hr.2009.56
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, Ishikawa S, Shimada K. 2010. Effects of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: The Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 28:1574–1583. doi:10.1097/HJH.0b013e3283395267
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Kanuri SH, Mehta JL. 2019. Role of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem. 26:1693–1700. doi:10.2174/0929867325666180508100950
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Cugini P, Uezono K, Sasaki H, Itoh K, Nishiura M, Shinkawa K. 1990. Circadian variations of total renin, active renin, plasma renin activity and plasma aldosterone in clinically healthy young subjects. Horm Metab Res. 22:636–639. doi:10.1055/s-2007-1004991
   PubMed Web of Science ®Google Scholar
• Kessler T, Schunkert H. 2021. Coronary artery disease genetics enlightened by genome-wide association studies. JACC Basic Transl Sci. 6:610–623. doi:10.1016/j.jacbts.2021.04.001
   PubMedGoogle Scholar
• Kim S, Kim NH, Kim YK, Yoo JH, Shin SN, Ko JS, Kim YK, Rhee SJ, Yun KH, Lee EM, et al. 2012. The number of endothelial progenitor cells is decreased in patients with non-dipper hypertension. Korean Circ J. 42:329–334. doi:10.4070/kcj.2012.42.5.329
   PubMedGoogle Scholar
• Kim S, Lee KY, Kim NH, Abbott RD, Kim C, Lee SK, Kim SH, Shin C. 6 2020. Relationship of obstructive sleep apnoea severity and subclinical systemic atherosclerosis. Eur Respir J. 55:1900959. doi:10.1183/13993003.00959-2019.
   PubMed Web of Science ®Google Scholar
• Kojetin D, Wang Y, Kamenecka TM, Burris TP. 2011. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol. 6:131–134. doi:10.1021/cb1002575
   PubMed Web of Science ®Google Scholar
• Kojetin DJ, Burris TP. 2014. REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov. 13:197–216. doi:10.1038/nrd4100
   PubMed Web of Science ®Google Scholar
• Kool MJ, Wijnen JA, Derkx FH, Struijker Boudier HA, Van Bortel LM. 1994. Diurnal variation in prorenin in relation to other humoral factors and hemodynamics. Am J Hypertens. 7:723–730. doi:10.1093/ajh/7.8.723
   PubMed Web of Science ®Google Scholar
• Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO. 2015. Circadian rhythms of hemostatic factors in tetraplegia: A double-blind, randomized, placebo-controlled cross-over study of melatonin. Spinal Cord. 53:285–290. doi:10.1038/sc.2014.243
   PubMed Web of Science ®Google Scholar
• Krasińska B, Paluszkiewicz L, Miciak-Lawicka E, Krasiński M, Rzymski P, Tykarski A, Krasiński Z. 2019. The effect of acetylsalicylic acid dosed at bedtime on the anti-aggregation effect in patients with coronary heart disease and arterial hypertension: A randomized, controlled trial. Cardiol J. 26:727–735. doi:10.5603/CJ.a2018.0142
   PubMedGoogle Scholar
• Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G. 2020. Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. Blood Press. 29:135–136. doi:10.1080/08037051.2020.1747696
   PubMedGoogle Scholar
• Krysiak R, Okopień B. 2012. Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure. Pharmacol Rep. 64:1466–1475. doi:10.1016/s1734-1140(12)70944-1
   PubMedGoogle Scholar
• Krystel-Whittemore M, Dileepan KN, Wood JG. 2016. Mast Cell: A multi-functional master cell. Front Immunol. 6:620. doi:10.3389/fimmu.2015.00620
   PubMed Web of Science ®Google Scholar
• Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, Busby SA, Garcia-Ordonez RD, Burris TP, Griffin PR. 2010. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1- hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol. 77:228–236. doi:10.1124/mol.109.060905
   PubMed Web of Science ®Google Scholar
• Kumar R, Thomas CM, Yong QC, Chen W, Baker KM. 2012. The intracrine renin–angiotensin system. Clin Sci (Lond). 123:273–284. doi:10.1042/CS20120089
   PubMed Web of Science ®Google Scholar
• Kumar S, Verma AK, Sagar V, Ranjan R, Sharma R, Tomar P, Bhatt D, Goyal Y, Alsahli MA, Almatroudi A, et al. 2021. Genotype variations and association between PAI-1 promoter region (4G/5G and −844G/A) and susceptibility to acute myocardial infarction and chronic stable angina. Cardiol Res Pract. 2021:5551031. doi:10.1155/2021/5551031
   PubMedGoogle Scholar
• Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. 1999. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 98:193–205. doi:10.1016/s0092-8674(00)81014-4
   PubMed Web of Science ®Google Scholar
• Kundel V, Reid M, Fayad Z, Ayappa I, Mani V, Rueschman M, Redline S, Shea S, Shah N. 2021. Sleep duration and vascular inflammation using hybrid positron emission tomography/magnetic resonance imaging: results from the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med. 17:2009–2018. doi:10.5664/jcsm.9382
   PubMedGoogle Scholar
• Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, Kara T, Caples SM, Pressman GS, Vasquez EC, et al. 2008. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 52:343–346. doi:10.1016/j.jacc.2008.04.027
   PubMed Web of Science ®Google Scholar
• Kwok CS, Kontopantelis E, Kuligowski G, Gray M, Muhyaldeen A, Gale CP, Peat GM, Cleator J, Chew‐Graham C, Loke YK, et al. 2018. Self-reported sleep duration and quality and cardiovascular disease and mortality: A dose-response meta-analysis. J Am Heart Assoc. 7:e008552. doi:10.1161/JAHA.118.008552
   PubMed Web of Science ®Google Scholar
• Labrecque G, Beauchamp D. 2003. Rhythms and pharmacokinetics. In: Redfern P, editor. Chronotherapeutics. London: Pharmaceutical Press; p. 75–110.
   Google Scholar
• Lack LC, Gradisar M, Van Someren EJWW, Wright HR, Lushington K. 2008. The relationship between insomnia and body temperatures. Sleep Med Rev. 12:307–317. doi:10.1016/j.smrv.2008.02.003
   PubMed Web of Science ®Google Scholar
• Lao XQ, Liu X, Deng HB, Chan TC, Ho KF, Wang F, Vermeulen R, Tam T, Wong MCS, Tse LA, et al. 2018. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J Clin Sleep Med. 14:109–117. doi:10.5664/jcsm.6894
   PubMed Web of Science ®Google Scholar
• Li D, Saldeen T, Romeo F, Mehta JL. 2000. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: The potential role of transcription factor NF-kappaB. Circulation. 102:1970–1976. doi:10.1161/01.cir.102.16.1970
   PubMed Web of Science ®Google Scholar
• Li J, Zheng D, Loffler KA, Wang X, McEvoy RD, Woodman RJ, Luo Y, Lorenzi-Filho G, Barbe F, Tripathi M, et al.; SAVE Investigators. 2020. Sleep duration and risk of cardiovascular events: The SAVE study. Int J Stroke. 15:858–865. doi:10.1177/1747493020904913
   PubMedGoogle Scholar
• Li J, Cao D, Huang Y, Chen Z, Wang R, Dong Q, Wei Q, Liu L. 2021. Sleep duration and health outcomes: An umbrella review. Sleep Breath. Epub ahead of print. PMID: 34435311. doi:10.1007/s11325-021-02458-1.
   Web of Science ®Google Scholar
• Liang B, Wang X, Zhang N, Yang H, Bai R, Liu M, Bian Y, Xiao C, Yang Z. 2015. Angiotensin-(1-7) attenuates angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-κB pathways in HUVECs. Cell Physiol Biochem. 35:2472–2482. doi:10.1159/000374047
   PubMedGoogle Scholar
• Lin C, Tang X, Zhu Z, Liao X, Zhao R, Fu W, Chen B, Jiang J, Qian R, Guo D. 2014. The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids Health Dis. 13:14. PMID: 24418196; PMCID: PMC4077102. doi:10.1186/1476-511X-13-14.
   PubMed Web of Science ®Google Scholar
• Liu L, Cao Q, Guo Z, Dai Q. 2016. Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: A meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich). 18:153–158. doi:10.1111/jch.12639
   PubMedGoogle Scholar
• Long AR. 1931. Cardiovascular renal disease: a report of a case three thousand years ago. Arch Pathol. 12:92–94.
   Google Scholar
• Loredo JS, Ancoli-Israel S, Dimsdale JE. 2001. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens. 14:887–892. doi:10.1016/s0895-7061(01)02143-4
   PubMed Web of Science ®Google Scholar
• Lubrano V, Balzan S. 2016. Roles of LOX-1 in microvascular dysfunction. Microvasc Res. 105:132–140. doi:10.1016/j.mvr.2016.02.006
   PubMed Web of Science ®Google Scholar
• Lui MM, Tse HF, Mak JC, Lam JC, Lam DC, Tan KC, Ip MS. 2013. Altered profile of circulating endothelial progenitor cells in obstructive sleep apnea. Sleep Breath. 17:937–942. doi:10.1007/s11325-012-0781-4
   PubMedGoogle Scholar
• Ma Y, Sun S, Peng CK, Fang Y, Thomas RJ. 2017. Ambulatory blood pressure monitoring in Chinese patients with obstructive sleep apnea. J Clin Sleep Med. 13:433–439. doi:10.5664/jcsm.6498
   PubMedGoogle Scholar
• Mackman N, Tilley RE, Key NS. 2007. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 27:1687–1693. doi:10.1161/ATVBAHA.107.141911
   PubMed Web of Science ®Google Scholar
• Madej A, Buldak L, Basiak M, Szkrobka W, Dulawa A, Okopien B. 2009. The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines. Int J Clin Pharmacol Ther. 47:686–694. doi:10.5414/cpp47686
   PubMed Web of Science ®Google Scholar
• Magagna A, Abdel-Haq B, Favilla S, Taddei S, Salvetti A. 1994. Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients. Blood Press. 3:236–241. doi:10.3109/08037059409102263
   PubMedGoogle Scholar
• Maiolino G, Bisogni V, Soranna D, Pengo MF, Pucci G, Vettor R, Fava C, Colussi GL, Bilo G, Lombardi C, et al.; Sleep Disorders Working Group of the Italian Society of Hypertension. 2021. Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis. Sleep Med Rev. 59:101497. doi:10.1016/j.smrv.2021.101497
   PubMedGoogle Scholar
• Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, et al. 2001. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens. 19:1167–1176. doi:10.1097/00004872-200106000-00023
   PubMed Web of Science ®Google Scholar
• Mander BA, Winer JR, Walker MP. 2017. Sleep and human aging. Neuron. 94:19–36. doi:10.1016/j.neuron.2017.02.004
   PubMed Web of Science ®Google Scholar
• Martin RJ, Cicutto LC, Ballard RD. 1990. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis. 141:33–38. doi:10.1164/ajrccm/141.1.33
   PubMed Web of Science ®Google Scholar
• Martínez-García M et al. (2013). Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension. JAMA, 310(22), 2407 10.1001/jama.2013.281250
   PubMed Web of Science ®Google Scholar
• Martinez-Nicolas A, Guaita M, Santamaría J, Montserrat JM, Má R, Madrid JA. 2017. Circadian impairment of distal skin temperature rhythm in patients with sleep-disordered breathing: The effect of CPAP. Sleep. 40:31–37. doi:10.1093/sleep/zsx067
   Google Scholar
• Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, et al. 2011 May 17. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 57:2020–2028. doi:10.1016/j.jacc.2010.11.022
   PubMed Web of Science ®Google Scholar
• Mason IC, Grimaldi D, Reid KJ, Warlick CD, Malkani RG, Abbott SM, Zee PC. 2022 Mar 22. Light exposure during sleep impairs cardiometabolic function. Proc Natl Acad Sci U S A. 119:e2113290119. doi:10.1073/pnas.2113290119
   PubMedGoogle Scholar
• Masuda Y, Emoto N, Nonaka H, Yagita K, Todo T, Okamura H, Yokoyama M, Hirata K. 2009. Role of angiotensin and the clock system in the circadian regulation of plasminogen activator inhibitor-1. Kobe J Med Sci. 54:E264–271. PMID: 19628967.
   PubMedGoogle Scholar
• Matavelli LC, Siragy HM. 2015. AT2 receptor activities and pathophysiological implications. J Cardiovasc Pharmacol. 65:226–232. doi:10.1097/FJC.0000000000000208
   PubMed Web of Science ®Google Scholar
• Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, et al. 2004. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation. 109:2792–2800. doi:10.1161/01.CIR.0000131860.80444.AB
   PubMed Web of Science ®Google Scholar
• Meng QJ, McMaster A, Beesley S, Lu WQ, Gibbs J, Parks D, Collins J, Farrow S, Donn R, Ray D, et al. 2008. Ligand modulation of REV-ERBalpha function resets the peripheral circadian clock in a phasic manner. J Cell Sci. 121:3629–3635. doi:10.1242/jcs.035048
   PubMed Web of Science ®Google Scholar
• Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M. 2007. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc Res. 76:506–516. doi:10.1016/j.cardiores.2007.07.008
   PubMed Web of Science ®Google Scholar
• Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. 2001. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev. 15:995–1006. doi:10.1101/gad.873501
   PubMed Web of Science ®Google Scholar
• Mochel JP, Danhof M. 2015. Chronobiology and pharmacologic modulation of the renin-angiotensin-aldosterone system in dogs: What have we learned? Rev Physiol Biochem Pharmacol. 169:43–69. doi:10.1007/112_2015_27
   PubMedGoogle Scholar
• Mokros Ł, Kuczyński W, Franczak Ł, Białasiewicz P. 2017. Morning diastolic blood pressure may be independently associated with severity of obstructive sleep apnea in non-hypertensive patients: A cross-sectional study. J Clin Sleep Med. 13:905–910. doi:10.5664/jcsm.6664
   PubMedGoogle Scholar
• Montezano AC, Burger D, Paravicini TM, Chignalia AZ, Yusuf H, Almasri M, He Y, Callera GE, He G, Krause KH, et al. 2010. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ Res. 106:1363–1373. doi:10.1161/CIRCRESAHA.109.216036
   PubMed Web of Science ®Google Scholar
• Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM. 2014. Angiotensin II and vascular injury. Curr Hypertens Rep. 16:431. doi:10.1007/s11906-014-0431-2
   PubMed Web of Science ®Google Scholar
• Morris CJ, Purvis TE, Hu K, Scheer FA. 2016. Circadian misalignment increases cardiovascular disease risk factors in humans. Proc Natl Acad Sci U S A. 113:E1402–11. doi:10.1073/pnas.1516953113
   PubMed Web of Science ®Google Scholar
• Morris CJ, Purvis TE, Mistretta J, Hu K, Scheer FAJL. 2017. Circadian misalignment increases C-reactive protein and blood pressure in chronic shift workers. J Biol Rhythms. 32:154–164. doi:10.1177/0748730417697537
   PubMed Web of Science ®Google Scholar
• Moser M. 1997. Evolution of the treatment of hypertension from the 1940s to JNC V. Amer J Hyperten. 10:2S–8S. doi:10.1016/S0895-7061(97)00016-2
   PubMed Web of Science ®Google Scholar
• Muller JE, Tofler GH, Stone PH. 1989. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 79:733–743. doi:10.1161/01.cir.79.4.733
   PubMed Web of Science ®Google Scholar
• Muller JE. 1999. Circadian variation in cardiovascular events. Am J Hypertens. 12:35S–42S. doi:10.1016/s0895-7061(98)00278-7
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, Margallo V, Costa LM, Guimarães G, Cavalcante AH, Azevedo JC, de Souza F, Cardoso CR, Salles GF. 2015. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: A randomized controlled trial. Hypertension. 65:736–742. doi:10.1161/HYPERTENSIONAHA.114.04852
   PubMed Web of Science ®Google Scholar
• Naito Y, Tsujino T, Matsumoto M, Okuda S, Sakoda T, Ohyanagi M, Masuyama T. 2009. The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats. Clin Exp Hypertens. 31:625–638. doi:10.3109/10641960903406993
   PubMed Web of Science ®Google Scholar
• Nakano S, Kobayashi N, Yoshida K, Ohno T, Matsuoka H. 2005. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats. Hypertens Res. 28:925–936. doi:10.1291/hypres.28.925
   PubMedGoogle Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189. doi:10.1097/00004872-200211000-00017
   PubMed Web of Science ®Google Scholar
• Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N. 2009. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice. J Mol Cell Cardiol. 46:545–552. doi:10.1016/j.yjmcc.2009.01.001
   PubMed Web of Science ®Google Scholar
• Oishi K. 2009. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders. Clin Exp Hypertens. 31:208–219. doi:10.1080/10641960902822468
   PubMed Web of Science ®Google Scholar
• Pache M, Kräuchi K, Cajochen C, Wirz-Justice A, Dubler B, Flammer J, Kaiser HJ. 2001. Cold feet and prolonged sleep-onset latency in vasospastic syndrome. Lancet. 358:125–126. doi:10.1016/S0140-6736(01)05344-2
   PubMed Web of Science ®Google Scholar
• Park JB, Schiffrin EL. 2002. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: Role of endothelin-1. Am J Hypertens. 15:164–169. doi:10.1016/s0895-7061(01)02291-9
   PubMed Web of Science ®Google Scholar
• Peñalvo JL, Mertens E, Muñoz-Cabrejas A, León-Latre M, Jarauta E, Laclaustra M, Ordovás JM, Casasnovas JA, Uzhova I, Moreno-Franco B. 2021. Work shift, lifestyle factors, and subclinical atherosclerosis in Spanish male workers: A mediation analysis. Nutrients. 13:1077. doi:10.3390/nu13041077
   PubMedGoogle Scholar
• Pépin JL, Tamisier R, Barone-Rochette G, Launois SH, Lévy P, Baguet JP. 2010. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 182:954–960. doi:10.1164/rccm.200912-1803OC
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Skatrud J. 2000. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 342:1378–1384. doi:10.1056/NEJM200005113421901
   PubMed Web of Science ®Google Scholar
• Petit E, Milano G, Lévi F, Thyss A, Bailleul F, Schneider M. 1988. Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Res. 48:1676–1679.
   PubMed Web of Science ®Google Scholar
• Petralito A, Mangiafico RA, Gibiino S, Cuffari MA, Miano MF, Fiore CE. 1982. Daily modifications of plasma fibrinogen platelets aggregation, Howell’s time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease. Chronobiologia. 9:195–201.
   PubMedGoogle Scholar
• Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foà A, Bernardi F. 2005. Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol. 25:646–649. doi:10.1161/01.ATV.0000153140.13148.e0
   PubMed Web of Science ®Google Scholar
• Piqueras L, Sanz MJ. 2020. Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways. Free Radic Biol Med. 157:38–54. doi:10.1016/j.freeradbiomed.2020.02.002
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Bagni B, Degli Uberti E, Montanari L, Cavallini R, Trasforini G, Margutti A, Ferlini M, Zanella M, Parti M. 1990. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens. 8:85–95. doi:10.1097/00004872-199001000-00013
   PubMed Web of Science ®Google Scholar
• Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. 2021. Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD. Int J Mol Sci. 22:6702. doi:10.3390/ijms22136702
   PubMedGoogle Scholar
• Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. 2002. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110:251–260. doi:10.1016/s0092-8674(02)00825-5
   PubMed Web of Science ®Google Scholar
• Queneau P, Decousus H, Ollagnier M, Cherrah Y, Perpoint B, Hocquart J. 1985. Chronocinétique du kétoprofène administré per os et en perfusion veineuse continue [Chronokinetics of ketoprofen administered orally and by continuous venous infusion]. Rev Rhum Mal Osteoartic. 52:403–408. French.
   PubMedGoogle Scholar
• Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris LL, Khorasanizadeh S, Burris TP, Rastinejad F. 2007. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol. 14:1207–1213. doi:10.1038/nsmb1344
   PubMed Web of Science ®Google Scholar
• Ramadan R, Dhawan SS, Binongo JN, Alkhoder A, Jones DP, Oshinski JN, Quyyumi AA. 2016. Effect of angiotensin II type I receptor blockade with valsartan on carotid artery Atherosclerosis: A double blind randomized clinical trial comparing valsartan and placebo (EFFERVESCENT). Am Heart J. 174:68–79. doi:10.1016/j.ahj.2015.12.021
   PubMedGoogle Scholar
• Rautureau Y, Paradis P, Schiffrin EL. 2011. Cross- talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids. 76:834–839. doi:10.1016/j.steroids.2011.02.015
   PubMed Web of Science ®Google Scholar
• Raymann RRJEM, Swaab DF, Van Someren EJW, Van Someran EJW. 2005. Cutaneous warming promotes sleep onset. Am J Physiol Integr Comp Physiol. 288:R1589–R1597. doi:10.1152/ajpregu.00492.2004
   PubMed Web of Science ®Google Scholar
• Reinberg A, Gervais P, Morin M, Abulker C. 1971. Rythme circadien humain du seuil de la réponse bronchique à l’acétylcholine [Human circadian rhythm of the threshold bronchial response to acetylcholine]. C R Acad Hebd Seances Acad Sci D. 272:1879–1881. French.
   PubMedGoogle Scholar
• Reinberg A, Gervais P, Morin M, Abulker C. 1974. Circadian rhythms in response in the threshold of bronchial response to acetylcholine in healthy and asthmatic subjects. In: Scheving LE, Halberg F, Pauly JE, editors. Chronobiology. Toyko, Japan: Igaku Shion Ltd.; p. 174–178.
   Google Scholar
• Reinberg A. 1983. Clinical chronopharmacology. In: Reinberg A, Smolensky MH, editors. Biological rhythms and medicine. Cellular, metabolic, physiopathologic, and pharmacologic aspects. New York: Springer-Verlag; p. 211–263.
   Google Scholar
• Reyman TA, Barraco RA, Cockburn A. 1976. Histopathological examination of an Egyptian mummy. Bull N Y Acad Med. 52:506–516.
   PubMedGoogle Scholar
• Rijo-Ferreira F, Takahashi JS. 2019 Dec 17. Genomics of circadian rhythms in health and disease. Genome Med. 11:82. doi:10.1186/s13073-019-0704-0
   PubMed Web of Science ®Google Scholar
• Rizza S, Longo S, Piciucchi G, Romanello D, Mavilio M, Montagna M, Coppeta L, Martelli E, Magrini A, Federici M. 2020. Carotid intimal medial thickness in rotating night shift is related to IL1β/IL6 axis. Nutr Metab Cardiovasc Dis. 30:1826–1832. doi:10.1016/j.numecd.2020.05.028
   PubMedGoogle Scholar
• Rosales C, Tang D, Geng YJ. 2015. CD1d serves as a surface receptor for oxidized cholesterol induction of peroxisome proliferator-activated receptor-γ. Atherosclerosis. 239:224–231. doi:10.1016/j.atherosclerosis.2015.01.004
   PubMedGoogle Scholar
• Sahu S, Patil CR, Kumar S, Apparsundaram S, Goyal RK. 2022. Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation. Mol Cell Biochem. 477:225–240. doi:10.1007/s11010-021-04275-2
   PubMedGoogle Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:10.1161/HYPERTENSIONAHA.115.06981
   PubMed Web of Science ®Google Scholar
• Sampaio WO, Souza Dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. 2007. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 49:185–192. doi:10.1161/01.HYP.0000251865.35728.2f
   PubMed Web of Science ®Google Scholar
• Santos RA, E Silva ACS, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, et al. 2003. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 100:8258–8263. doi:10.1073/pnas.142869100
   PubMed Web of Science ®Google Scholar
• Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. 2004. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 43:527–537. doi:10.1016/j.neuron.2004.07.018
   PubMed Web of Science ®Google Scholar
• Scheer FA, Michelson AD, Frelinger AL 3rd, Evoniuk H, Kelly EE, McCarthy M, Doamekpor LA, Barnard MR, Shea SA. 2011. The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One. 6:e24549. doi:10.1371/journal.pone.0024549
   PubMed Web of Science ®Google Scholar
• Scheer FA, Shea SA. 23 2014. Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle. Blood. 123:590–593. doi:10.1182/blood-2013-07-517060.
   PubMed Web of Science ®Google Scholar
• Schein AS, Kerkhoff AC, Coronel CC, Plentz RD, Sbruzzi G. 2014. Continuous positive airway pressure reduces blood pressure in patients with obstructive sleep apnea; a systematic review and meta-analysis with 1000 patients. J Hypertens. 32:1762–1773. doi:10.1097/HJH.0000000000000250
   PubMed Web of Science ®Google Scholar
• Schilperoort M, van den Berg R, Bosmans LA, van Os BW, Dollé MET, Smits NAM, Guichelaar T, van Baarle D, Koemans L, Berbée JFP, et al. 2020. Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice. J Pineal Res. 68:e12614. doi:10.1111/jpi.12614
   PubMedGoogle Scholar
• Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. 2003. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol. 35:473–481. doi:10.1016/s0022-2828(03)00051-8
   PubMed Web of Science ®Google Scholar
• Sekizuka H, Osada N, Akashi YJ. 2018. The factors affecting the non-dipper pattern in Japanese patients with severe obstructive sleep apnea. Intern Med. 57:1553–1559. doi:10.2169/internalmedicine.0029-17
   PubMedGoogle Scholar
• Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, Kume K, Lee CC, van der Horst GT, Hastings MH, et al. 2000. Interacting molecular loops in the mammalian circadian clock. Science. 288:1013–1019. doi:10.1126/science.288.5468.1013
   PubMed Web of Science ®Google Scholar
• Sher S, Green A, Khatib S, Dagan Y. 2021. The possible role of endozepines in sleep regulation and biomarker of Process S of the Borbély sleep model. Chronobiol Int. 38:122–128. doi:10.1080/07420528.2020.1849252
   PubMed Web of Science ®Google Scholar
• Silva GM, França-Falcão MS, Calzerra NTM, Luz MS, Gadelha DDA, Balarini CM, Queiroz TM. 2020. Role of renin-angiotensin system components in atherosclerosis: Focus on Ang-II, ACE2, and Ang-1-7. Front Physiol. 11:1067. doi:10.3389/fphys.2020.01067
   PubMedGoogle Scholar
• Skogstad M, Mamen A, Lunde LK, Ulvestad B, Matre D, Aass HCD, Øvstebø R, Nielsen P, Samuelsen KN, Skare Ø, et al. 2019. Shift work including night work and long working hours in industrial plants increases the risk of atherosclerosis. Int J Environ Res Public Health. 16:521. doi:10.3390/ijerph16030521
   PubMed Web of Science ®Google Scholar
• Smolensky M, Scott P, Albright D, McGovern J. 1986. Circadian differences in theophylline effect during constant-rate infusion with aminophylline. Ann Rev Chronopharmacol. 3:139–142.
   Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. 2010. Administration-time-dependent effects of blood pressure-lowering medications: Basis for the chronotherapy of hypertension. Blood Press Monit. 15:173–180. doi:10.1097/MBP.0b013e32833c7308
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. 2015. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 21:773–790. doi:10.2174/1381612820666141024150542
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16. doi:10.1016/j.smrv.2016.02.003
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Geng YJ. 2021. Chronotherapy of cardiac and vascular disease: Timing medications to circadian rhythms to optimize treatment effects and outcomes. Curr Opin Pharmacol. 57:41–48. doi:10.1016/j.coph.2020.10.014
   PubMedGoogle Scholar
• Snoep JD, Hovens MM, Pasha SM, Frölich M, Pijl H, Tamsma JT, Huisman MV. 2009. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension. 54:1136–1142. doi:10.1161/HYPERTENSIONAHA.109.134825
   PubMed Web of Science ®Google Scholar
• Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, Shin Y, Liu J, Cameron MD, Noel R, et al. 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 485:62–68. doi:10.1038/nature11030
   PubMed Web of Science ®Google Scholar
• Souza SP, Santos RB, Santos IS, Parise BK, Giatti S, Aielo AN, Cunha LF, Silva WA, Bortolotto LA, Lorenzi-Filho G, et al. 2021. Obstructive sleep apnea, sleep duration, and associated mediators with carotid intima-media thickness: The ELSA-Brasil Study. Arterioscler Thromb Vasc Biol. 41:1549–1557. doi:10.1161/ATVBAHA.120.315644
   PubMedGoogle Scholar
• Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. 2014. Classical renin-angiotensin system in kidney physiology. Compr Physiol. 4:1201–1228. doi:10.1002/cphy.c130040
   PubMed Web of Science ®Google Scholar
• Suarez-Martinez E, Husain K, Ferder L. 2014. Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice. Ther Adv Cardiovasc Dis. 8:224–236. doi:10.1177/1753944714542593
   PubMedGoogle Scholar
• Sugiura T, Dohi Y, Takagi Y, Yoshikane N, Ito M, Suzuki K, Nagami T, Iwase M, Seo Y, Ohte N. 2020. Impacts of lifestyle behavior and shift work on visceral fat accumulation and the presence of atherosclerosis in middle-aged male workers. Hypertens Res. 43:235–245. doi:10.1038/s41440-019-0362-z
   PubMed Web of Science ®Google Scholar
• Tao F, Cao Z, Jiang Y, Fan N, Xu F, Yang H, Li S, Zhang Y, Zhang X, Sun L, et al. 2021. Associations of sleep duration and quality with incident cardiovascular disease, cancer, and mortality: A prospective cohort study of 407,500 UK biobank participants. Sleep Med. 81:401–409. doi:10.1016/j.sleep.2021.03.015
   PubMedGoogle Scholar
• Taylor NAS, Machado-Moreira CA, van den Heuvel AMJ, Caldwell JN. 2014. Hands and feet: physiological insulators, radiators and evaporators. Eur J Appl Physio. 114:2037–2060. doi:10.1007/s00421-014-2940-8
   PubMed Web of Science ®Google Scholar
• Thompson RC, Allam AH, Lombardi GP, Wann LS, Sutherland ML, Sutherland JD, Soliman MA, Frohlich B, Mininberg DT, Monge JM, et al. 2013. Atherosclerosis across 4000 years of human history: The Horus study of four ancient populations. Lancet. 381:1211–1222. doi:10.1016/S0140-6736(13)60598-X
   PubMed Web of Science ®Google Scholar
• Toraldo DM, Peverini F, De Benedetto M, De Nuccio F. 2013. Obstructive sleep apnea syndrome: Blood viscosity, blood coagulation abnormalities, and early atherosclerosis. Lung. 191:1–7. doi:10.1007/s00408-012-9427-3
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Psaltopoulou T, Androulakis E, Papageorgiou N, Papaioannou S, Oikonomou E, Synetos A, Stefanadis C. 2015. Oxidative stress and early atherosclerosis: Novel antioxidant treatment. Cardiovasc Drugs Ther. 29:75–88. doi:10.1007/s10557-014-6562-5
   PubMedGoogle Scholar
• Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL. 2003. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol. 81:159–167. doi:10.1139/y02-164
   PubMedGoogle Scholar
• Tsujino T, Naito Y, Masuyama T. 2006. Circadian variations in gene expression of renin-angiotensin system. Nihon Rinsho. 64 Suppl:84–88. Japanese.
   Google Scholar
• Turgeon RD, Althouse AD, Cohen JB, Enache B, Hogenesch JB, Johansen ME, Mehta R, Meyerowitz-Katz G, Ziaeian B, Hiremath S. 2021. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension - Con side of the argument. Hypertension. 78:871–878. doi:10.1161/HYPERTENSIONAHA.121.16501
   PubMed Web of Science ®Google Scholar
• Ueda HR, Chen W, Adachi A, Wakamatsu H, Hayashi S, Takasugi T, Nagano M, Nakahama K, Suzuki Y, Sugano S, et al. 2002. A transcription factor response element for gene expression during circadian night. Nature. 418:534–539. doi:10.1038/nature00906
   PubMed Web of Science ®Google Scholar
• Undar L, Ertuğrul C, Altunbaş H, Akça S. 1999. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: A possible association with interleukin-6. Thromb Haemost. 81:571–575. doi:10.1055/s-0037-1614526
   PubMed Web of Science ®Google Scholar
• van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE. 2003. The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood. 101:1841–1844. doi:10.1182/blood-2002-07-2181
   PubMed Web of Science ®Google Scholar
• Veglio F, Pietrandrea R, Ossola M, Vignani A, Amgeli A. 1987. Circadian rhythm of the angiotensin converting enzyme (ACE) in serum of healthy adult subjects. Chronobiologia. 14:21–15.
   PubMedGoogle Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, et al. 1994. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 24:793–801. doi:10.1161/01.hyp.24.6.793
   PubMed Web of Science ®Google Scholar
• Virchow R. 1989. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI–Atheromatous affection of arteries. 1858. Nutr Rev. 47:23–25. doi:10.1111/j.1753-4887.1989.tb02747.x
   PubMed Web of Science ®Google Scholar
• Vollenweider S, Wirz-Justice A, Flammer J, Orguel S, Kraeuchi K. 2008. Chronobiological characterization of women with primary vasospastic syndrome: Body heat loss capacity in relation to sleep initiation and phase of entrainment. Am J Physiol Integr Comp Physiol. 294:R630–R638. doi:10.1152/ajpregu.00609.2007
   PubMed Web of Science ®Google Scholar
• Vyas MV, Garg AX, Iansavichus AV, Costella J, Donner A, Laugsand LE, Janszky I, Mrkobrada M, Parraga G, Hackam DG. 2012 Jul 26. Shift work and vascular events: systematic review and meta-analysis. BMJ. 345:e4800. doi:10.1136/bmj.e4800
   PubMed Web of Science ®Google Scholar
• Wang CY, Wen MS, Wang HW, Hsieh IC, Li Y, Liu PY, Lin FC, Liao JK. 2008. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation. 118:2166–2173. doi:10.1161/CIRCULATIONAHA.108.790469
   PubMed Web of Science ®Google Scholar
• Wessel N, Malberg H, Heringer-Walther S, Schultheiss HP, Walther T. 2007. The angiotensin-(1-7) receptor agonist AVE0991 dominates the circadian rhythm and baroreflex in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 49:67–73. doi:10.1097/FJC.0b013e31802cffe9
   PubMedGoogle Scholar
• White C, Smolensky MH, Sanders SW, Buchi KN, Moore JG. 1991. Day-night and individual differences in response to constant-rate ranitidine infusion. Chronobiol Int. 8:56–66. doi:10.3109/07420529109063919
   PubMed Web of Science ®Google Scholar
• White MJ, Kodaman NM, Harder RH, Asselbergs FW, Vaughan DE, Brown NJ, Moore JH, Williams SM. 2015. Genetics of plasminogen activator inhibitor-1 (PAI-1) in a Ghanaian population. PLoS One. 10:e0136379. doi:10.1371/journal.pone.0136379
   PubMedGoogle Scholar
• Winther K, Hillegass W, Tofler GH, Jimenez A, Brezinski DA, Schafer AI, Loscalzo J, Williams GH, Muller JE. 1992. Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. Am J Cardiol. 70:1051–1055. doi:10.1016/0002-9149(92)90359-7
   PubMed Web of Science ®Google Scholar
• Xie M, Tang Q, Nie J, Zhang C, Zhou X, Yu S, Sun J, Cheng X, Dong N, Hu Y, et al. 2020. BMAL1-downregulation aggravates Porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress. Circ Res. 126:e15–e29. Epub 2020 Feb 11. PMID: 32078488. doi:10.1161/CIRCRESAHA.119.315502.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang J, Jiang T, Monslow J, Tang SY, Todd L, Puré E, Chen L, FitzGerald GA. 2020. Bmal1 deletion in myeloid cells attenuates atherosclerotic lesion development and restrains abdominal aortic aneurysm formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 40:1523–1532. doi:10.1161/ATVBAHA.120.314318
   PubMedGoogle Scholar
• Yap T, Affandi JS, Reid CM, Xu D. 2020. Translating research evidence into clinical practice: A reminder of important clinical lessons in management of resistant hypertension through a case study in general practice. BMJ Case Rep. 13:e235007. doi:10.1136/bcr-2020-235007
   PubMedGoogle Scholar
• Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, Waitt GM, Parks DJ, Pearce KH, Wisely GB, et al. 2007. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science. 318:1786–1789. doi:10.1126/science.1150179
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fang B, Emmett MJ, Damle M, Sun Z, Feng D, Armour SM, Remsberg JR, Jager J, Soccio RE, et al. 2015. Gene regulation. Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. Science. 348:1488–1492. doi:10.1126/science.aab3021
   PubMed Web of Science ®Google Scholar
• Zhou B, Wang Q, Zhao Z, Feng X. 2020. A Systematic review of the efficacy and safety of aspirin when delivered at different medication times for the primary and secondary prevention of cardiovascular and cerebrovascular diseases. Ther Innov Regul Sci. 54:1339–1348. doi:10.1007/s43441-020-00156-w
   PubMedGoogle Scholar